Faculty 2017

rectangle1010 MICHAEL PINSKY KEYNOTE SPEAKER

APPLIED CARDIOVASCULAR PHYSIOLOGY IN THEATRE: MEASURING THE CARDIOVASCULAR EFFECTS OF PROPOFOL ANESTHESIA

mpinsky

 

This year’s keynote speaker is Michael Pinsky, Professor of Critical Care Medicine with secondary appointments in Cardiovascular Diseases, Clinical & Translational Science, Anesthesiology, and Bioengineering at the University of Pittsburgh, Pennsylvania, USA. He has published >230 peer-reviewed papers, >210 chapters, and 24 books. His CV is a book in and by itself. He is Editor-in-Chief of eMedicine’s Critical Care Medicine and is on numerous editorial boards and international programs. He received numerous awards from prestigious universities. He is a member of the ACGME Review Board for Pulmonary & CCM. His research interests are heart-lung interactions, cardiovascular insufficiency, hemodynamic monitoring, sepsis, mechanical ventilation, and health services research and quality of life after critical illness. He will use his superb lecture skills to give his lecture, Applied cardiovascular physiology in theatre: Measuring the cardiovascular effects of propofol anesthesia.

rectangle1010 MICHAEL AVRAM

FRONT-END KINETICS: THE FIRST TWO MIN AFTER INJECTING PROPOFOL


mavram

 

Michael Avram received his B.S. in Chemistry from Michigan State University and his Ph.D. in Pharmacology from Loyola University of Chicago. He joined the faculty of the Department of Anesthesiology at Northwestern University Feinberg School of Medicine, where he is a tenured Associate Professor of Anesthesiology and Director of the Mary Beth Donnelley Clinical Pharmacology Core Facility. He is a diplomat of the American Board of Clinical Pharmacology, an Executive Editor of Anesthesiology, and a member of the Editorial Board of Clinical Pharmacology & Therapeutics. He has published > 130 peer-reviewed papers. He developed PK models that describe the early kinetics of rapidly acting IV administered drugs. These models help describe interindividual variability in response to these agents, which often have low clinical margins of safety. We are looking forward to his lecture “Front-end kinetics: the first two min after injecting propofol”.

 

rectangle1010 GERHARD SCHNEIDER

THE FUTURE OF DEPTH OF ANESTHESIA MONITORING: FROM PROBABILISTIC TO MECHANISM-BASED MONITORING


gschneider

 

Gerhard Schneider is Professor and Chair of the Department of Anaesthesiology at the Technische Universität Münich. He is past chairman of the ESA Scientific Subcommittee on Neurosciences. His research focuses on mechanisms of anesthesia-induced unconsciousness, detection, prevention and treatment of awareness, recall, and their sequels, and monitoring of anesthetic effects on the brain. Prof. Schneider will tell us how we should navigate towards an appropriate depth of anesthesia: ”The Future of depth of anesthesia monitoring: from probabilistic to mechanism-based monitoring”.

 

rectangle1010 ANDREW KOFKE

NEUROTOXICITY OF INHALED AGENTS AFTER PROLONGED ADMINISTRATION


akofkeAndrew Kofke is Professor of Anesthesiology and Critical Care at the Hospital of the University of Pennsylvania, Department of Anesthesiology and Critical Care, Perelman School of Medicine (2001) and Professor of Neurology, Department of Neurology, Perelman School of Medicine (2014). He is past president of the Society for Neuroscience in Anesthesiology and Critical Care. He has published > 100 manuscripts, books, and book chapters. He studied Medicine at the University of Pittsburgh. During his residency and fellowship at the Massachusetts General Hospital, Boston, 1979-1983, he wrote the chapter “Closed circuit anesthesia” in “Clinical Anesthesia Procedures of the Massachusetts General Hospital”, 3rd Edition. His work has included neurotoxicity of opioids and more recently of inhaled agents. His NAVAt lecture will focus on the latter: “Neurotoxicity of inhaled agents after prolonged administration.”

 

rectangle1010 ROBERT PEARCE

AS CLOSE AS IT GETS: INTRAVENOUS SEVOFLURANE

 

rpearceRobert Pearce is Professor and R.M. Waters Distinguished Chair of Anesthesiology, University of Wisconsin, Madison, Wisconsin, USA. He has been a member of the Scientific Advisory Board of the Association of University Anesthesiologists, Associate Editor of Anesthesiology, and a member of the Committee on Research of the ASA. Research in the Pearce laboratory is focused on the mechanisms by which general anesthetics alter brain function. They are particularly interested in understanding how modulation of GABA receptors impairs memory – a fundamental endpoint of anesthesia. They utilize expressed recombinant receptors and hippocampal brain slices to investigate the roles of specific subunit combinations and cell types in the control of learning and memory. In a sense, the Pearce lab is also working on the ultimate closed circuit administration methods, intravenous sevoflurane, which he will tell us all about in his lecture “As closed as it gets: intravenous sevoflurane”.

rectangle1010 JOSEPH FISHER

THE RIVAL™


jfisher
Joseph Fisher is Professor at the Department of Anesthesia and Pain Management, Toronto General Hospital. His group has developed several innovative approaches regarding the delivery of inhaled agents. He has supervised approximately 25 graduate students; has authored or co-authored about 145 peer-reviewed publications; has 30 issued patents, with about a dozen patents pending. At NAVAt II (2014), he introduced us to the concept of isocapnic hyperventilation. At this NAVAt V lustrum edition, Prof. Fisher will explain us the technical aspects of a novel system that allows one to deliver inhaled agents with any ventilator and that makes agent usage largely independent of fresh gas flow by combining an in-circle vaporizer with an agent reflector. Details to be heard at his lecture “The RIVAL™ ”, digital in-line vaporizer plus anesthetic shield: maximum control and maximum efficiency of anesthetic delivery.

 

rectangle1010 F. JAVIER BELDA

AUTOMATED LOW FLOW SEDATION

 

fbelda

 

 

F. Javier Belda is Professor of Anesthesiology, Department of Surgery, University of Valencia. He is the head of the Department of Anesthesia and Critical Care of University Clinic Hospital, University of Valencia in Spain. He has published extensively (> 100 PubMed cited references) on various aspects of ventilation. He will share with us his clinical experience with the use of inhaled agents in the ICU using an ICU ventilator turned anesthesia ventilator in his lecture “Automated low flow sedation”.

 

rectangle1010 ANDRES MEISER

THE ANACONDA


ameiser

 

 

Andres Meiser is Senior Doctor in the Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, Saarland University, University Medical Centre, Homburg/Saar, Germany. He has considerable experience with the use of the ANACONDA™ system to deliver inhaled agents in the ICU, which he described in several peer reviewed manuscripts. We look forward to learn from him about the technical aspects of the ANACONDA™ system used to deliver inhaled agent outside the operating room.

 

rectangle1010 HAGEN BOMBERG

THE MIRUS™ SYSTEM   

 

hbomberg

 

 

Hagen Bomberg is a resident in the Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, Saarland University, University Medical Centre, Homburg/Saar, Germany. As the first author of the initial reports on the MIRUS™ system, he will share with us his hands-on experience with the MIRUS™ system. The system can be used to deliver isoflurane, sevoflurane, and desflurane with any ventilator.Professor Berry will examine how inhaled anesthetic agents can be recycled.

 

rectangle1010 ANDRE DE WOLF

 

adewolfAndre De Wolf is Professor at the Department of Anesthesiology at Northwestern University, Chicago, IL, USA. He is one of the world’s experts on anesthesia for liver transplantation, and while working at University Pittsburgh Medical Center from 1981 until 1996, closely collaborated with Thomas Starzl, the surgeon who invented liver transplantation. He developed a secondary interest in pharmacokinetics and pharmacodynamics of inhaled anesthetics, which started to lead a second life in and by itself after meeting Jan Hendrickx when he started a residency at the University of Pittsburgh in 1992. Two speakers at the fifth NAVAt meeting, Michael Pinsky and Andrew Kofke, were his teachers and colleagues in Pittsburgh.

 

rectangle1010 JAN HENDRICKX

 

jhendrickxJan Hendrickx is a member of the Department of Anesthesiology in Aalst, Belgium, and an alumnus of the Department of Anesthesiology of Pittsburgh and of Stanford, CA, USA. He has a life-long interest in the quantitative aspects of low flow and closed circuit anesthesia. He is the immediate past chair of the ESA subcommittee on Equipment, Monitoring and Ultrasound, member of the ESA N2O task force, and member of the ESA Patient Safety and Quality committee. Andre and Jan’s joint research ended up bringing them into contact with Philip Peyton and Michel Struys. He looks forward to continue to learn from his attendings at NAVAt V.

 

rectangle1010 PHILIPPE PEYTON   


ppeyton

 

Philip Peyton is Associate Professor at Austin Hospital, Melbourne. He was a member of the ENIGMA I and II (Evaluation of Nitrous oxide In the Gas Mixture for Anaesthesia) trial group that confirmed the safety of N2O. He is a world-expert on how ventilation/perfusion mismatching affects anesthetic gas exchange. All four of them (Andre, Jan, Michel, and Philip) have lectured extensively during the first 4 NAVAt meetings.

 

 

rectangle1010 MICHEL STRUYS   


mstruysMichel Struys is Professor and Chair at the Department of Anesthesiology, University of Groningen and University Medical Center Groningen and is affiliated as Professor of Anesthesia at the Ghent University, Belgium. His research group is one of the world leading groups in anesthetic pharmacology, including PK/PD modeling, drug interaction research and drug administration systems such as TCI and closed-loop. He is an editor of the British Journal of Anaesthesia, senior editor of Anesthesia and Analgesia, and a former associated editor of Anesthesiology. He is a Past President of the International Society of Anesthetic Pharmacology, past member of the Committee on Pharmacology of the ESA, and board member of EuroSIVA. He has been a speaker at NAVAt and will chair at NAVAt V.

 

rectangle1010 PATRICK WOUTERS   


pwoutersPatrick Wouters is Professor and Chair of the Department of Anesthesia and Perioperative Medicine and Professor of Clinical Physiology at Ghent University, Belgium. He has published extensively on right ventricular function. He has chaired the ESA Scientific Subcommittee on Clinical and Experimental Circulation and the Subcommittee of the European Association of Cardiothoracic Anaesthesiologists on Echocardiography. He will share some of his expertise as chair at NAVAt V.

 

rectangle1010 GEERT VANDENBROUCKE    


gvdbroucke

 

 

Geert Vandenbroucke, Chair of the Department of Anesthesiology, CCM, and Pain Medicine at the OLV hospital, has been unrelenting in his support for NAVAt and will be hosting NAVAt for the 5th time.

rectangle1010 JAN VERBEKE    


jverbeke

 

Jan Verbeke will co-chair NAVAt V. He graduated from Ghent University, Belgium, and is board certified in Anesthesiology and CCM. He was actively involved in the development of CCM in Belgium. He is director of the OLV CCM department. He is a former member of the Belgian Accreditation Board of Anesthesiology and CCM. He is secretary of the Belgian Professional Society of Physician-Specialists in CCM. He has a special interest in ventilator and nutritional aspects of CCM.

rectangle1010 KOEN DE DECKER    


kddecker

 

Koen De Decker graduated from Antwerp University, Belgium, and is board certified in Anesthesiology and CCM. He is co-director of the OLV CCM department. He is member of the Belgian CCM accreditation council, member of the scientific committee of the Belgian Society of Intensive Care Medicine (SIZ), and director of the OLV CCM residency program. He has a special interest in cardiovascular anesthesia and intensive care medicine, with special emphasis on the management of end-stage heart disease (mechanical support, heart transplantation). He will co-chair NAVAt V.